159 related articles for article (PubMed ID: 196753)
1. Combination chemotherapy with adriamycin and cyclophosphamide (with or without radiation therapy) for carcinoma of the lung.
Herman TS; Jones SE; McMahon LJ; Lloyd RE; Heusinkveld RS; Miller RC; Salmon SE
Cancer Treat Rep; 1977 Aug; 61(5):875-9. PubMed ID: 196753
[No Abstract] [Full Text] [Related]
2. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
Sanz Ortiz J; Saiz García F
Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
[No Abstract] [Full Text] [Related]
3. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.
Takita H; Marabella PC; Edgerton F; Rizzo D
Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692
[No Abstract] [Full Text] [Related]
4. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
[TBL] [Abstract][Full Text] [Related]
5. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
[No Abstract] [Full Text] [Related]
6. Cyclophosphamide, adriamycin, and DTIC polychemotherapy in advanced small cell lung cancer.
Saiontz HI; Dalton RJ; Eagan RT
Cancer Treat Rep; 1977; 61(3):481-3. PubMed ID: 194692
[No Abstract] [Full Text] [Related]
7. The treatment of lung cancer.
Zubrod CG; Selawry O
Adv Intern Med; 1978; 23():451-67. PubMed ID: 204171
[No Abstract] [Full Text] [Related]
8. Four-drug combination chemotherapy in extensive non-small cell lung cancer: a Southwest Oncology Group Pilot Study.
Livingston RB; Mira J; O'Bryan RM
Cancer Treat Rep; 1981; 65(1-2):143-4. PubMed ID: 6164484
[No Abstract] [Full Text] [Related]
9. Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.
Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
Cancer Treat Rep; 1982 Dec; 66(12):2005-11. PubMed ID: 6291763
[TBL] [Abstract][Full Text] [Related]
10. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P
Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987
[TBL] [Abstract][Full Text] [Related]
11. Combination cyclophosphamide, doxorubicin, and cisplatin (CAP) chemotherapy for extensive non-small cell carcinomas of the lung.
Davis S; Rambotti P; Park YK
Cancer Treat Rep; 1981; 65(11-12):955-8. PubMed ID: 7028257
[TBL] [Abstract][Full Text] [Related]
12. [A randomized comparison of radiotherapy with CAP and CVP in non-small cell lung cancer].
Yoneda S; Homma T; Yoshida S; Noguchi Y; Fukuda Y; Nakata M; Sakura M
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2870-1. PubMed ID: 3019254
[No Abstract] [Full Text] [Related]
13. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer.
Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM
Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy in advanced cancer of the lung].
Fleischer I; Wainstein R; Jovtis SL; Gibson AM; Barousse AP
Medicina (B Aires); 1979; 39(4):472-6. PubMed ID: 545078
[No Abstract] [Full Text] [Related]
15. Combination chemotherapy followed by radiation therapy in patients with regional stage III unresectable non-small cell lung cancer.
Fram R; Skarin A; Balikian J; Amato D; Leslie N; Malcolm A; Frei E
Cancer Treat Rep; 1985 Jun; 69(6):587-90. PubMed ID: 2990710
[TBL] [Abstract][Full Text] [Related]
16. Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer.
Higby DJ; Wilbur D; Wallace HJ; Henderson ES; Weiss R
Cancer Treat Rep; 1977 Aug; 61(5):869-73. PubMed ID: 329980
[TBL] [Abstract][Full Text] [Related]
17. [VP-16, vincristine, adriamycin and cyclophosphamide (EVAC) in patients with small-cell lung cancer].
Abad-Esteve A; Rosell R; Moreno I; Fernández-Marcial C; Roselló M; Ribas Mundó M
Med Clin (Barc); 1988 Apr; 90(14):569-72. PubMed ID: 2840536
[No Abstract] [Full Text] [Related]
18. Phase II studies of polychemotherapy regimens in small cell lung cancer.
Eagan RT; Carr DT; Lee RE; Frytak S; Rubin J; Coles DT
Cancer Treat Rep; 1977; 61(1):93-5. PubMed ID: 861966
[No Abstract] [Full Text] [Related]
19. Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung.
Edmonson JH; Lagakos SW; Selawry OS; Perlia CP; Bennett JM; Muggia FM; Wampler G; Brodovsky HS; Horton J; Colsky J; Mansour EG; Creech R; Stolbach L; Greenspan EM; Levitt M; Israel L; Ezdinli EZ; Carbone PP
Cancer Treat Rep; 1976 Jul; 60(7):925-32. PubMed ID: 1009523
[TBL] [Abstract][Full Text] [Related]
20. Combination chemoimmunotherapy for extensive non-oat cell lung cancer.
Issell BF; Valdivieso M; Hersh EM; Richman S; Gutterman JU; Bodey GP
Cancer Treat Rep; 1978 Jul; 62(7):1059-63. PubMed ID: 356968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
